BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33014778)

  • 1. Liquid Biopsy of Extracellular Vesicle-Derived miR-193a-5p in Colorectal Cancer and Discovery of Its Tumor-Suppressor Functions.
    Wei R; Chen L; Qin D; Guo Q; Zhu S; Li P; Min L; Zhang S
    Front Oncol; 2020; 10():1372. PubMed ID: 33014778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-193a-5p inhibits migration of human HT-29 colon cancer cells via suppression of metastasis pathway.
    Shirafkan N; Shomali N; Kazemi T; Shanehbandi D; Ghasabi M; Baghbani E; Ganji M; Khaze V; Mansoori B; Baradaran B
    J Cell Biochem; 2019 May; 120(5):8775-8783. PubMed ID: 30506718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of miR-193a-5p and miR-146 a-5p Expression Induces G1 Arrest in Colorectal Cancer through Targeting of MDM2/p53.
    Noorolyai S; Baghbani E; Aghebati Maleki L; Baghbanzadeh Kojabad A; Shanehbansdi D; Khaze Shahgoli V; Mokhtarzadeh A; Baradaran B
    Adv Pharm Bull; 2020 Jan; 10(1):130-134. PubMed ID: 32002372
    [No Abstract]   [Full Text] [Related]  

  • 4. Long Non-Coding RNA Cancer Susceptibility 9 (CASC9) Up-Regulates the Expression of ERBB2 by Inhibiting miR-193a-5p in Colorectal Cancer.
    Ding Y; Li X; Zhang Y; Zhang J
    Cancer Manag Res; 2020; 12():1281-1292. PubMed ID: 32110102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of miR-193a-3p is associated with poor prognosis in colorectal cancer.
    Lin M; Duan B; Hu J; Yu H; Sheng H; Gao H; Huang J
    Oncol Lett; 2017 Jul; 14(1):1061-1067. PubMed ID: 28693274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer.
    Ren X; Zhang H; Cong H; Wang X; Ni H; Shen X; Ju S
    Pathol Oncol Res; 2018 Oct; 24(4):739-744. PubMed ID: 29520570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of extracellular vesicle-delivered miR-185-5p in the plasma of patients as an indicator for advanced adenoma and colorectal cancer.
    Shi YJ; Fang YX; Tian TG; Chen WP; Sun Q; Guo FQ; Gong PQ; Li CM; Wang H; Hu ZQ; Li XX
    J Transl Med; 2023 Jun; 21(1):421. PubMed ID: 37386465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.
    Jin L; Li H; Wang J; Lin D; Yin K; Lin L; Lin Z; Lin G; Wang H; Ying X; Wang L; Zhang Y; Teng L
    J Cell Biochem; 2019 Apr; 120(4):6188-6197. PubMed ID: 30304561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-146a-5p and miR-193a-5p Synergistically Inhibited the Proliferation of Human Colorectal Cancer Cells (HT-29 cell line) through ERK Signaling Pathway.
    Noorolyai S; Baghbani E; Shanehbandi D; Khaze Shahgoli V; Baghbanzadeh Kojabad A; Mansoori B; Hajiasgharzadeh K; Mokhtarzadeh A; Baradaran B
    Adv Pharm Bull; 2021 Sep; 11(4):755-764. PubMed ID: 34888223
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
    Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
    Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
    Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
    J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of miR-193a-5p in the proliferation and apoptosis of hepatocellular carcinoma.
    Wang JT; Wang ZH
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7233-7239. PubMed ID: 30468466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-193a-3p suppresses the colorectal cancer cell proliferation and progression through downregulating the PLAU expression.
    Lin M; Zhang Z; Gao M; Yu H; Sheng H; Huang J
    Cancer Manag Res; 2019; 11():5353-5363. PubMed ID: 31354344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
    Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
    Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
    Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively.
    Pu Y; Zhao F; Cai W; Meng X; Li Y; Cai S
    Clin Exp Metastasis; 2016 Apr; 33(4):359-72. PubMed ID: 26913720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
    Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
    J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The miR-193a-5p/NCX2/AKT axis promotes invasion and metastasis of osteosarcoma.
    Chen R; Ning Y; Zeng G; Zhou H; Zhou L; Xiao P; Li Z; Zhou J
    J Cancer; 2021; 12(19):5903-5913. PubMed ID: 34476004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
    Sahami-Fard MH; Kheirandish S; Sheikhha MH
    Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.